Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Sponsor
Roswell Park Cancer Institute (Other)
Overall Status
Terminated
CT.gov ID
NCT03751449
Collaborator
(none)
10
1
2
25.9
0.4

Study Details

Study Description

Brief Summary

This trial studies how well exercise and nutrition education work in improving physical function and quality of life in older breast cancer survivors. Exercise and nutrition education may help to improve the level of fitness, cardiovascular health, and quality of life in breast cancer survivors.

Detailed Description

PRIMARY OBJECTIVES:
  1. To assess the effect of a home-based aerobic and resistance exercise and nutrition education intervention in overweight or obese, sedentary, older (65 years and above) breast cancer survivors on physical function (6-minute walk test) and quality of life compared to standard of care.
SECONDARY OBJECTIVES:
  1. To assess the effect of a home-based aerobic and resistance exercise and nutrition education intervention on diet quality, sleep, anxiety, depression, source of motivation for exercise, and immune function in overweight or obese, sedentary, older (65 years and above) breast cancer survivors compared to standard of care.
EXPLORATORY OBJECTIVES:
  1. To determine how body composition (dual X-ray absorptiometry [DEXA]) and weight maintenance are affected by a 12-week aerobic and resistance exercise training program among older (65 years and above), sedentary, overweight and obese breast cancer survivors.

  2. To compare differences in the above outcomes among older (65 years and above), sedentary, overweight and obese breast cancer survivors who completed a home-based aerobic and resistance exercise training program versus those who did not receive the intervention, standard of care.

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP I (ACTIVE TREATMENT): Participants complete a home-based aerobic and resistance exercise program and receive nutrition education for 12 weeks.

GROUP II (WAITLIST): Participants are placed on a waitlist for 12 weeks and then complete a home-based aerobic and resistance exercise program and receive nutrition education for 12 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Exercise and Nutrition Intervention in Older Breast Cancer Survivors - The WIN CA Study
Actual Study Start Date :
Mar 25, 2019
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
May 21, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group I (active treatment)

Participants complete a home-based aerobic and resistance exercise program and receive nutrition education for 12 weeks.

Other: Educational Intervention
Receive nutrition education
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Behavioral: Exercise Intervention
    Complete home-based aerobic and resistance exercise program

    Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Active Comparator: Group II (waitlist)

    Participants are placed on a waitlist for 12 weeks and then complete a home-based aerobic and resistance exercise program and receive nutrition education for 12 weeks.

    Other: Educational Intervention
    Receive nutrition education
    Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Behavioral: Exercise Intervention
    Complete home-based aerobic and resistance exercise program

    Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Activity levels for all participants will be collected using the Fitbit applications and a weekly activity log. [Up to 2 years]

      Will measure the effect on physical function (6-minute walk test). Activity levels for all participants will be collected using the Fitbit applications and/or a weekly activity log.

    2. Quality of life as assessed by the Self Geriatric Assessment Measure (GA-Self Assessment) [Up to 2 years]

      Will measure the effect of a home-based aerobic and resistance exercise and nutrition education intervention on quality of life.

    Secondary Outcome Measures

    1. Diet quality as assessed by the ASA24 website [Up to 2 years]

      Will measure the effect of a home-based aerobic and resistance exercise and nutrition education intervention on diet quality.

    2. Sleep as assessed by the Pittsburgh Sleep Quality Index (PSQI) [Up to 2 years]

      The PSQI measures the quality and pattern of sleeps in adults. There are 19 items. Each item is weighted on a 0-3 interval scale.

    3. Anxiety and the effect of a home-based aerobic and resistance exercise and nutrition education intervention [Up to 2 years]

      Will measure anxiety as assessed by the State Trait Anxiety Inventory (STAI-Y1)e STAI questionnaire consists of 40 questions with 20 items allocated to each of the State Anxiety and Trait Anxiety subscales. The scores for each subtest range from 20 to 80, with higher scores indicating higher levels of anxiety

    4. motivation for exercise as assessed by the Behavioral Regulation for Exercise Questionnaire (BREQ-2) [Up to 2 years]

      A 19 item questionnaire that measures the stages of the self-determination continuum with respect to motivation to exercise with a 5 point Likert scale (0=not true for me, 4=very true for me)

    5. Centers for Epidemiologic Studies Depression Scale (CESD-R) [Up to 2 years]

      A self reported 20 item scale that measures depressive symptoms. A higher score denotes greater depressive symptoms.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Men or women with a history of breast cancer who have completed treatment >=3 months ago (not including hormonal therapy, Zometa, or other non-chemotherapy/radiation cancer treatment at the discretion of the principal investigator)

    • Physically inactive, defined as not meeting 150 minutes or 2 hours and 30 minutes a week of vigorous-intensity exercise

    • Overweight or obese, defined as having a body mass index (BMI) between 26 kg/m2 and 42 kg/m2, inclusive

    • Meeting criteria for participation in low to moderate risk exercise based on the American College of Sports and Medicine (ACSM) guideline

    • Providing informed consent indicating understanding the investigational nature of this study by signing an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedures

    Exclusion Criteria:
    • Metastatic breast cancer

    • Orthopedic or neuromuscular disorders that preclude participation in exercise

    • Any history of myocardial infarction (MI), angina pectoris, or congestive heart failure

    • High risk for moderate exercise based on ACSM risk classification

    • Pregnant or nursing

    • Unwilling or unable to follow protocol requirements

    • Any condition which - in the investigator?s opinion - deems the participant an unsuitable candidate to participate in this study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Roswell Park Cancer Institute Buffalo New York United States 14263

    Sponsors and Collaborators

    • Roswell Park Cancer Institute

    Investigators

    • Principal Investigator: Tracey O'Connor, Roswell Park Cancer Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Roswell Park Cancer Institute
    ClinicalTrials.gov Identifier:
    NCT03751449
    Other Study ID Numbers:
    • i 67518
    • NCI-2018-01704
    • i 67518
    First Posted:
    Nov 23, 2018
    Last Update Posted:
    Jun 6, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 6, 2022